doi: 10.1124/pharmrev.123.001140 24 GutierrezRFonsecaESimonSA
Once the expiration date (BUD) passes, the medication may degrade or lose its efficacy, which could impact your treatment outcomes
NICE guidance (NG28 for type 2 diabetes, TA875 for semaglutide 2.4 mg, and TA664 for liraglutide 3 mg) recommends regular monitoring of patients on GLP-1 therapy, with particular attention to tolerability and adverse effects
For those living with endometriosis this is an exciting development
The $150 billion metabolic health opportunity will belong to companies that can combine science, scale, access, and evidence
In addition, the binding of fatty acids to specific receptors also raises intracellular calcium levels